HSBC HOLDINGS PLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 114 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50,727
-61.3%
16,155
+40.5%
0.00%
Q2 2022$131,000
-49.8%
11,500
-59.5%
0.00%
Q1 2022$261,000
+4.0%
28,429
+69.7%
0.00%
Q4 2021$251,000
-64.0%
16,749
-38.1%
0.00%
-100.0%
Q3 2021$698,000
-37.2%
27,067
-36.3%
0.00%0.0%
Q2 2021$1,111,000
+173.6%
42,460
+269.2%
0.00%
Q1 2021$406,000
+2.8%
11,500
-26.3%
0.00%
-100.0%
Q4 2020$395,000
-37.7%
15,610
-6.9%
0.00%0.0%
Q3 2020$634,000
+28.9%
16,766
+45.8%
0.00%0.0%
Q2 2020$492,000
+100.8%
11,500
-11.1%
0.00%0.0%
Q1 2020$245,00012,9390.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders